icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012
Back grey_arrow_rt.gif
 
 
 
Everolimus-Facilitated Reduction of Tacrolimus Provides Comparable Efficacy and Superior Renal Function versus Standard Tacrolimus in De Novo Liver Transplant Recipients: 24-month Results of a Randomized Trial
 
 
  Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
 
Faouzi Saliba1, Paolo De Simone2, Frederik Nevens3, Luciano De Carlis4, Herold J. Metselaar5, Susanne Beckebaum6, Sven Jonas7, Debra Sudan8, Lutz Fischer9, John Fung10, Gaohong Dong11, Patricia Lopez12, Guido Junge12
1Hôpital Paul Brousse, Villejuif, France; 2Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 3University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium; 4Niguarda "Cà Granda" Hospital, Milan, Italy; 5Erasmus MC, University Hospital Rotterdam, Rotterdam, The Netherlands; 6University Hospital Essen, Essen, Germany; 7University Medical Center Leipzig, Leipzig, Germany; 8Duke University Medical Center, Durham, NC, United States; 9University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; 10Cleveland Clinic Foundation, Cleveland, OH, United States, 11Novartis Pharmaceuticals Corporation, New Jersey, United States, 12Novartis Pharma AG, Basel, Switzerland

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif